Total Funding
71
72
Total FundingPost-IPO Debt raised
Growth Score
0 pts
Heat Score
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
63525
Pharos iBio Co. specializing in drug development that develops treatments for intractable diseases.
About the Company
Pharos iBio is a biotechnology firm that focuses on clinical-stage drug discovery and development. The company utilizes artificial intelligence and big data platforms to design specific treatments for rare and refractory diseases. This digital platform analyzes large biological datasets to identify target proteins and optimize new chemical
compounds. The business develops an ongoing pipeline of novel drug candidates primarily for various oncology applications.
